How long do clinical trial phases take?

Before a potential new therapy can reach patients, it goes through several clinical trial phases that test an intervention for both safety and effectiveness. Looking at the big picture, it takes approximately ten years for a new treatment to complete the journey from initial discovery to the marketplace. Clinical trials alone take six to seven years on average to complete.

Continue reading

“Participation for progress,” a new whitepaper in partnership with Antidote, BrightFocus Foundation, and PatientPoint

Antidote partnered with the BrightFocus Foundation and PatientPoint to survey more than 650 patients living with cognitive disorders and their care partners. We sought to understand patterns of diagnosis as well as reasons patients do or do not take part in clinical research — with the ultimate goal of recognizing opportunities to improve patient engagement around research participation.

Continue reading

How to run the perfect clinical trial recruitment campaign

Many factors play into running a successful clinical trial. Patient recruitment has an infamous reputation for taking a long time and slowing down the research process. However, with the right patient recruitment strategies, enrolling volunteers doesn’t have to halt your trial’s progress. 

Continue reading

COPD resources: Where to find the information and support you need

More than 16 million Americans have chronic obstructive pulmonary disease, commonly referred to as COPD, and millions more have it but don’t know it. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Emphysema and chronic bronchitis are the two most prevalent conditions that contribute to the development of COPD. Signs of COPD include ongoing cough, ...

Continue reading

Advertising clinical trials: Do's and Don'ts

A major challenge in clinical trial advertising is being creative within the scope of institutional review board (IRB) and FDA guidelines, as well as distribution channel rules. While it can take more time and research to craft copy within such narrow parameters, it is definitely still possible to engage patients without breaking the rules.

Continue reading

Interview with the Hepatitis B Foundation

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. We’re proud to partner with them to help people living with hepatitis B find and take part in clinical trials.

Continue reading

Virtual or traditional trials: Considerations for making trial design decisions

When it comes to running a clinical trial, researchers have been getting creative, trading traditional processes for virtual opportunities. This has become especially apparent in light of the COVID-19 pandemic. 

Continue reading

Where to find hepatitis B support

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). For some, hepatitis B can be a short-term illness, but for others, it can become a chronic condition that can lead to serious health issues like cirrhosis or liver cancer. The best way to prevent hepatitis B is by getting vaccinated, which usually occurs shortly after birth.

Continue reading

Ulcerative colitis research round-up

Ulcerative colitis, a common form of inflammatory bowel disease (IBD), is characterized by continuous inflammation of the colon. There is no known cure for ulcerative colitis and flare-ups may recur. That’s why scientists are actively researching treatments and therapies for people living with ulcerative colitis. 

Continue reading

3 ways to approach recruitment for clinical trials

Finding the right people to participate in clinical trials is no easy task, but with the right approach, sponsors can hit the sweet spot in reaching their recruitment goals. 

Continue reading

Get our latest posts in your inbox.